How long do you need antiplatelet therapy after TAVR?
•
2 min read
Following transcatheter aortic valve replacement (TAVR), balancing the risk of ischemic events with the risk of major bleeding is crucial, with recent meta-analyses showing that dual antiplatelet therapy (DAPT) is associated with an increased risk of bleeding compared with single antiplatelet therapy (SAPT). The optimal duration of antiplatelet therapy after TAVR has shifted significantly, moving away from prolonged dual-therapy regimens for most patients.
